David Sullivan

14.7k citations
211 papers · 9.6k · 4 hit papers · h-index 53

Impact in

Papers in

David Sullivan

203 papers receiving 9.2k citations

David Sullivan's Hit Papers

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial 2014 · 570 citations
5700+6+13Years since publication200400600

Peers

David Sullivan
Comparison fields: 5 of 160
  • Endocrinology, Diabetes and Metabolism 1.5k
  • Surgery 3.7k
  • Biochemistry 389
  • Cardiology and Cardiovascular Medicine 1.3k
  • Nutrition and Dietetics 950
Replace L. Masana with:
L. Masana Spain
Jiří Fröhlich Canada
Philip W. Connelly Canada
Željko Reiner Croatia
Maria F. Lopes‐Virella United States
Matteo Pirro Italy
Rodolfo Paoletti Italy
Dimitri P. Mikhailidis United Kingdom
Giuseppe Danilo Norata Italy
G. Russell Warnick United States
David Sullivan relative to L. Masana Spain L. Masana's profile →
Citations per field
00.5×1.7×
L. Masana · 1×
Citations per year

Countries citing papers authored by David Sullivan

Since Specialization
Citations

This map shows the geographic impact of David Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sullivan more than expected).

Fields of papers citing papers by David Sullivan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sullivan. The network helps show where David Sullivan may publish in the future.

Co-authors

The 25 scholars most cited alongside David Sullivan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Sullivan Line = papers co-authored together David Sullivan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 211 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Health benefits of herbs and spices: the past, the present, the future
Hit paper breakdown →
2006723
2
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
Hit paper breakdown →
2014570
3
Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance
Hit paper breakdown →
2014421
4
Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients
Hit paper breakdown →
2012370
5 2010258
6 1990224
7 2017212
8 2002196
9 1985179
10 2013177
11 1997155
12 2012148
13 1986145
14 2008143
15 2004142
16 1985140
17 2015132
18 1997130
19 2014127
20 1990127

About David Sullivan

David Sullivan is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Cancer Research and Molecular Biology, having authored 211 papers that have together received 9.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (81 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (31 papers), Cancer, Lipids, and Metabolism (28 papers), Lipid metabolism and disorders (14 papers), Fatty Acid Research and Health (12 papers), Metabolomics and Mass Spectrometry Studies (12 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Cholesterol and Lipid Metabolism (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.5k citations), Surgery (3.7k citations), Biochemistry (389 citations), Cardiology and Cardiovascular Medicine (1.3k citations) and Nutrition and Dietetics (950 citations). David Sullivan has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include Anthony Keech, Scott M. Wasserman, Robert C. Scott, Peter Clifton, Gerald F. Watts, Philip J. Barter, David S. Celermajer, Paul J. Nestel, Russell Scott and T. A. B. Sanders. Their work appears in journals such as Atherosclerosis, Circulation, Pathology, Journal of clinical lipidology and The Medical Journal of Australia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact